AVGO Broadcom shed roughly 15% on Thursday after revenue guidance fell short of expectations. The selloff wiped an estimated $300bn from its market cap. Analysts are split on what comes next. Oppenheimer raised its target to $535. Macquarie went the other way, downgrading to Neutral with a $437 target. Despite the carnage, short interest sits at just 1.1% of free float. The pain is concentrated in the options market, not short books.
ROKU is drawing fresh short sellers fast. Short interest jumped 49.4% in one week to 7.9% of free float — the sharpest weekly rise in months. The stock fell 3.9% today and 7.4% over the week. Morgan Stanley held firm, raising its target to $170. Availability remains vast at 4,314%, making it cheap and easy to borrow.
TEM Tempus AI also drew more bearish attention. Short interest surged 32% in a week to 20.4% of float. Shares fell 4.3% on the day. Borrow is tight at 28.9% availability, suggesting bears are crowded in.
CIEN Ciena reports Q2 2026 results today. BF.B Brown-Forman and PVH also report this morning. The week's biggest name arrives Wednesday — ORCL Oracle drops Q4 2026 results on June 10. Cloud growth and AI infrastructure demand will be the key focus.
Director Jack Cogen filed over $230M in CRWV CoreWeave sales this week. Five insiders at NVTS Navitas Semiconductor filed sales totalling more than $115M. RL Ralph Lauren's founder filed a $99.7M sale at $378.25 per share. Across markets, insiders are locking in gains at elevated prices.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
